An upgrade to Buy from Nomura helps Informatica (INFA +5.2%) rebound a bit from the bloodletting...

An upgrade to Buy from Nomura helps Informatica (INFA+5.2%) rebound a bit from the bloodletting it saw thanks to its Q3 warning. Nomura argues the risk/reward is favorable, but cautions Informatica's license revenue will likely take several quarters to recover due to sales execution issues. Yesterday, Evercore argued Informatica, which faces strong competition from an IBM that has aggressively expanded its analytics software lineup, appears to be dealing with company-specific problems.